These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35660003)

  • 1. The future of stem cell therapies of Alzheimer's disease.
    Wang ZB; Wang ZT; Sun Y; Tan L; Yu JT
    Ageing Res Rev; 2022 Sep; 80():101655. PubMed ID: 35660003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives.
    Tong LM; Fong H; Huang Y
    Exp Mol Med; 2015 Mar; 47(3):e151. PubMed ID: 25766620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research.
    Bi FC; Yang XH; Cheng XY; Deng WB; Guo XL; Yang H; Wang Y; Li J; Yao Y
    Transl Neurodegener; 2021 Aug; 10(1):27. PubMed ID: 34372927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease.
    Cha MY; Kwon YW; Ahn HS; Jeong H; Lee YY; Moon M; Baik SH; Kim DK; Song H; Yi EC; Hwang D; Kim HS; Mook-Jung I
    Stem Cells Transl Med; 2017 Jan; 6(1):293-305. PubMed ID: 28170178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Human Stem Cell Implantation in Alzheimer's Disease.
    Chan HJ; Yanshree ; Roy J; Tipoe GL; Fung ML; Lim LW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.
    Csöbönyeiová M; Polák Š; Danišovič L
    Rev Neurosci; 2016 Jul; 27(5):457-64. PubMed ID: 26812864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.
    Fan X; Sun D; Tang X; Cai Y; Yin ZQ; Xu H
    Med Res Rev; 2014 Sep; 34(5):957-78. PubMed ID: 24500883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
    Young JE; Goldstein LSB
    Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.
    Sproul AA
    Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
    Tcw J
    Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
    Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
    Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
    Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Parkinson's Disease.
    Xu Y; Wang S; Zhu P
    Curr Stem Cell Res Ther; 2023; 18(2):154-162. PubMed ID: 35473516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Alzheimer's Disease Using Human Brain Organoids.
    Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S
    Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating stem cell trials for Alzheimer's disease.
    Hunsberger JG; Rao M; Kurtzberg J; Bulte JWM; Atala A; LaFerla FM; Greely HT; Sawa A; Gandy S; Schneider LS; Doraiswamy PM
    Lancet Neurol; 2016 Feb; 15(2):219-230. PubMed ID: 26704439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
    Fan W; Sun Y; Shi Z; Wang H; Deng J
    Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous Induced Pluripotent Stem Cell-Based Cell Therapies: Promise, Progress, and Challenges.
    Madrid M; Sumen C; Aivio S; Saklayen N
    Curr Protoc; 2021 Mar; 1(3):e88. PubMed ID: 33725407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.